Bayer Net Worth 2010-2024 | BAYRY

Interactive chart of historical net worth (market cap) for Bayer (BAYRY) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Bayer net worth as of December 24, 2024 is $19.29B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $19.295B $51.553B
Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $728.847B 75.49
Novo Nordisk (NVO) Denmark $381.440B 27.51
Johnson & Johnson (JNJ) United States $347.829B 14.11
AbbVie (ABBV) United States $310.275B 16.33
Merck (MRK) United States $248.031B 16.48
AstraZeneca (AZN) United Kingdom $202.626B 17.24
Novartis AG (NVS) Switzerland $198.493B 13.19
Pfizer (PFE) United States $149.382B 10.22
Sanofi (SNY) $121.080B 10.97
Innoviva (INVA) United States $1.117B 9.29